ArticleBMC pulmonary medicine2026

Clinical factors and practical strategies to optimize amikacin liposome inhalation suspension therapy in refractory Mycobacterium avium complex pulmonary disease.

Fumio Kurosaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.